3 immunology-csbrp
-
Upload
prasad-csbr -
Category
Health & Medicine
-
view
456 -
download
0
Transcript of 3 immunology-csbrp
Disorders of Disorders of Immunity – 3Immunity – 3
HypersensitivityHypersensitivityDr.CSBR.Prasad, Dr.CSBR.Prasad,
M.D.M.D.
APR-2015-CSBRP
Disorders of Immune system
Hypersensitivity reactionsHypersensitivity reactions
Autoimmune diseasesAutoimmune diseases
Immunologic deficiency syndrome Immunologic deficiency syndrome – AIDS– AIDS
Amyloidosis Amyloidosis APR-2015-CSBRP
Disorders of Immune system
Hypersensitivity reactionsHypersensitivity reactionsDefinition:Definition:The terms The terms HypersensitivityHypersensitivity or or AllergicAllergic
statestate refer to an refer to an altered immune statealtered immune state following exposure to an antigen, following exposure to an antigen, whereby whereby subsequent contact results in subsequent contact results in tissue injury tissue injury or or a diseasea disease..
Hypersensitivity refers to undesirable (damaging and sometimes fatal) reactions produced by the normal immune system
APR-2015-CSBRP
Disorders of Immune system
Hypersensitivity reactionsHypersensitivity reactions
Protective Damaging
APR-2015-CSBRP
Hypersensitivity reactionsHypersensitivity reactions
Exogenous antigensExogenous antigens Dust, pollen, food, drugs, Dust, pollen, food, drugs,
microbiological agents, chemicals microbiological agents, chemicals and blood productsand blood products
Endogenous antigensEndogenous antigens Blood transfusion, graft rejection, Blood transfusion, graft rejection,
autoimmune reactionautoimmune reaction
APR-2015-CSBRP
Hypersensitivity reactionsHypersensitivity reactions
ClassificationClassification ( (Gell & CoombsGell & Coombs)) Type-IType-I Immediate or Immediate or AnaphylacticAnaphylactic type type Type-IIType-II Cytotoxic type Cytotoxic type Type-IIIType-III Immune complex mediated Immune complex mediated
typetype Type-IVType-IV Delayed hypersensitivity type Delayed hypersensitivity type Type-VType-V Anti-receptor type Anti-receptor type Type-VIType-VI Miscellaneous Miscellaneous
APR-2015-CSBRP
Hypersensitivity reactionsHypersensitivity reactions
Type I disease ( Anaphylactic type)Type I disease ( Anaphylactic type) AnaphylaxisAnaphylaxis Bronchial asthma Bronchial asthma Infantile eczema Infantile eczema Immediate drug reactionImmediate drug reaction Shock from rupture of hydatid cystShock from rupture of hydatid cyst Insect bite reactionsInsect bite reactions
Formation of Formation of IgE AbIgE Ab – release of vasoactive – release of vasoactive amines & spasmogenic substances from amines & spasmogenic substances from basophilsbasophils and and mast cellsmast cells followed by followed by recruitment by other inflammatory cellsrecruitment by other inflammatory cells
APR-2015-CSBRP
Hypersensitivity reactionsHypersensitivity reactions
Type II disease (cytotoxic type)Type II disease (cytotoxic type) Hemolytic transfusion reactionsHemolytic transfusion reactions HDNHDN Autoimmune Hemolytic anemiaAutoimmune Hemolytic anemia Goodpasture’s syndromeGoodpasture’s syndrome
Binding of IgG, IgM to Ag on target Binding of IgG, IgM to Ag on target cell and phagocytosis or lysis of cell and phagocytosis or lysis of target celltarget cell
APR-2015-CSBRP
Hypersensitivity reactionsHypersensitivity reactions Type III disorder (Immune complex Type III disorder (Immune complex
disease)disease) SLESLE Acute glomerulonephritisAcute glomerulonephritis RARA PANPAN Erythema nodosumErythema nodosum
Ag-Ab complex – activate complement – Ag-Ab complex – activate complement – attract neutrophils – release of lysosomal attract neutrophils – release of lysosomal enzymes and toxic free radicalsenzymes and toxic free radicals
APR-2015-CSBRP
Hypersensitivity reactionsHypersensitivity reactions
Type IV disorder (Cell Type IV disorder (Cell mediated/delayed mediated/delayed hypersensitivity)hypersensitivity) Caseous necrosis in TuberculosisCaseous necrosis in Tuberculosis Leprosy neuritisLeprosy neuritis Contact dermatitisContact dermatitis
Sensitized T lymphocytes – cell Sensitized T lymphocytes – cell mediated cytotoxicitymediated cytotoxicity
APR-2015-CSBRP
Hypersensitivity reactionsHypersensitivity reactions
Type V disorder (Type V disorder (Anti-receptor Anti-receptor typetype)) Grave’s diseaseGrave’s disease Myasthenia gravisMyasthenia gravis Insulin resistant diabetesInsulin resistant diabetes
Formed antibodies bind with receptors.Formed antibodies bind with receptors.Results can be excessive Results can be excessive activationactivation or or
blockadeblockade
APR-2015-CSBRP
Hypersensitivity reactionsHypersensitivity reactions
Type VI disorder (Miscellaneous)Type VI disorder (Miscellaneous)They are due to pure activation of They are due to pure activation of
alternate pathway of compelmentalternate pathway of compelment Gram negative endotoxic shockGram negative endotoxic shock PNHPNH
APR-2015-CSBRP
Type I HypersensitivityType I Hypersensitivity ( Anaphylactic type) ( Anaphylactic type)
Rapidly developing Rapidly developing immunological reactionimmunological reaction
Systemic reactionSystemic reaction – IV injection – IV injection of antigenof antigen
Local reactionLocal reaction – Skin / GIT / – Skin / GIT / Respiratory / ConjunctivalRespiratory / Conjunctival
APR-2015-CSBRP
Type I HypersensitivityType I Hypersensitivity ( Anaphylactic type) ( Anaphylactic type)
Reaction occurs in Reaction occurs in 2 phases2 phases Intial responseIntial response – occurs within 5-30 min – occurs within 5-30 min
after exposure to allergen & last for 60 after exposure to allergen & last for 60 min.min.Vasodilatation, vascular leakage, smooth Vasodilatation, vascular leakage, smooth muscle spasm/ glandular secretionmuscle spasm/ glandular secretion
Late phase responseLate phase response - Occurs after 2 – 8 - Occurs after 2 – 8 hours without additional exposure to Ag hours without additional exposure to Ag and last for daysand last for days
Infiltration by eosinophils, neutrophils, Infiltration by eosinophils, neutrophils, basophils, monocytes and CD4 T cellbasophils, monocytes and CD4 T cell
APR-2015-CSBRP
Mast cellsMast cellsNear blood vessels, nerves and in Near blood vessels, nerves and in
subepithelial sitessubepithelial sites Membrane bound granules Membrane bound granules
containing biologically active containing biologically active mediators mediators
Metachromatic granulesMetachromatic granules Activation by cross linking of IgE Fc Activation by cross linking of IgE Fc
receptor, C5a, C3a, cytokines (IL- receptor, C5a, C3a, cytokines (IL- 8), drugs (codeine, morphine)8), drugs (codeine, morphine)
APR-2015-CSBRP
APR-2015-CSBRP
Figure 6-12 Pathogenesis of immediate (type I) hypersensitivity reaction.
The late-phase reaction is dominated by leukocyte infiltration and tissue injury. TH2, T-helper type 2 CD4 cells.
APR-2015-CSBRP
Figure 15-10 A simplified scheme of the system of type 1 helper T (TH1) and type 2 helper (TH2) cells.
APR-2015-CSBRP
Type I HypersensitivityType I Hypersensitivity ( Anaphylactic type) ( Anaphylactic type)
Primary mediatorsPrimary mediators Biologenic aminesBiologenic amines::
Histamine – bronchial SM contractor, ↑ vascular Histamine – bronchial SM contractor, ↑ vascular permeability, ↑ secretionpermeability, ↑ secretion
Adenosine – Bronchoconstriction, Platelet Adenosine – Bronchoconstriction, Platelet aggregationaggregation
Chemotactic mediatorsChemotactic mediators – Eosinophils, – Eosinophils, NeutrophilsNeutrophils
EnzymesEnzymes – Proteases, Acid hydrolases – Proteases, Acid hydrolases Proteoglycans Proteoglycans – Heparin, chondroitin – Heparin, chondroitin
sulfatesulfateMajor site of action of HISTAMINE: Venules
APR-2015-CSBRP
Type I HypersensitivityType I Hypersensitivity ( Anaphylactic type) ( Anaphylactic type)
Secondary MediatorsSecondary Mediators LeukotriensLeukotriens:
C4 & D4 – vasoactive and spasmogenicC4 & D4 – vasoactive and spasmogenic B4- chemotactic for PMN, EØ, MonocytesB4- chemotactic for PMN, EØ, Monocytes
Prostoglandins D2Prostoglandins D2 – Bronchospasm, – Bronchospasm, ↑secretion↑secretion
PAFPAF – Pl. aggregation, release of – Pl. aggregation, release of histaminehistamine
CytokinesCytokines – Recruit & activate – Recruit & activate inflammatory cellsinflammatory cells
APR-2015-CSBRP
Figure 6-13 Activation of mast cells in immediate hypersensitivity and release of their mediators. ECF, eosinophil chemotactic factor; NCF, neutrophil chemotactic factor; PAF, platelet-activating factor.
APR-2015-CSBRP
Type I HypersensitivityType I Hypersensitivity ( Anaphylactic type) ( Anaphylactic type)
Immediate reactionImmediate reaction HistamineHistamine LeukotriensLeukotriens
Late phase reactionLate phase reaction PAFPAF TNF -αTNF -α CytokinesCytokinesEosinophilsEosinophils – major basic protein , EØ cationic – major basic protein , EØ cationic
protein, leukotriens C4, PAFprotein, leukotriens C4, PAFDirectly activate Mast cells to release Directly activate Mast cells to release
mediatorsmediators
APR-2015-CSBRP
Type I HypersensitivityType I Hypersensitivity ( Anaphylactic type) ( Anaphylactic type)
Systemic AnaphylaxisSystemic Anaphylaxis Antisera, Hormones, Enzymes, DrugsAntisera, Hormones, Enzymes, Drugs Itching, erythema, respiratory Itching, erythema, respiratory
distress, laryngeal edema, deathdistress, laryngeal edema, death Local AnaphylaxisLocal Anaphylaxis
Atopic allergy – Atopic allergy – Genetically Genetically determineddetermined ~10% of the population ~10% of the population
predisposition to develop reaction to predisposition to develop reaction to inhaled / ingested allergensinhaled / ingested allergens
Urticaria, angioedema, allergic Urticaria, angioedema, allergic rhinitis, asthmarhinitis, asthma
APR-2015-CSBRP
APR-2015-CSBRP
Type II HypersensitivityType II Hypersensitivity ( (Cytotoxic typeCytotoxic type))
Mediated by Abs to Mediated by Abs to cell surface Agscell surface Ags and components of and components of extracellular extracellular matrixmatrix
3 mechanisms3 mechanisms1.1. Complement dependent reactionComplement dependent reaction2.2. Antibody dependent cell mediated Antibody dependent cell mediated
cytotoxicity (ADCC)cytotoxicity (ADCC)3.3. Antibody mediated cellular Antibody mediated cellular
dysfunctiondysfunction
APR-2015-CSBRP
Complement dependent Complement dependent reactionreaction
Direct lysis – Direct lysis – Membrane Attack Complex – C5-9Membrane Attack Complex – C5-9
OpsonizationOpsonization Attachment of Ab/C3b fragment to Attachment of Ab/C3b fragment to
cell surfacecell surface
APR-2015-CSBRP
Opsonisation & cell lysisOpsonisation & cell lysis
APR-2015-CSBRP
Complement mediated Complement mediated lysis lysis
APR-2015-CSBRP
APR-2015-CSBRP
APR-2015-CSBRP
APR-2015-CSBRP
Complement dependent Complement dependent reactionreaction
Transfusion reactionsTransfusion reactions Erythrhroblastosis fetalisErythrhroblastosis fetalis Autoimmune Hemolytic anemiaAutoimmune Hemolytic anemia Pemphigus vulgaris – Ab against Pemphigus vulgaris – Ab against
desmosomesdesmosomes
APR-2015-CSBRP
Antibody dependent cell Antibody dependent cell mediated cytotoxicity mediated cytotoxicity
(ADCC)(ADCC) Target cells coated with IgG Ab are Target cells coated with IgG Ab are
killed by nonsensitized cells that killed by nonsensitized cells that have Fc receptorhave Fc receptor
Cell lysis without phagocytosisCell lysis without phagocytosis Mediated by monocytes, Mediated by monocytes,
neutrophils, eosinophils & NK cellsneutrophils, eosinophils & NK cells Parasite, tumor cell, graft rejectionParasite, tumor cell, graft rejection
APR-2015-CSBRP
ADCC – apoptosis by NK cellsADCC – apoptosis by NK cells
APR-2015-CSBRP
1.1. What is the % of Rh negativity?What is the % of Rh negativity?2.2. Which HDN is more common?Which HDN is more common?3.3. Which HDN is more severe?Which HDN is more severe?4.4. What is RhoGAM?What is RhoGAM?5.5. How do you assess transplacental bleed?How do you assess transplacental bleed?6.6. How do you assess anemia in a fetus?How do you assess anemia in a fetus?7.7. What are the other causes for Hydrops What are the other causes for Hydrops
fetalis?fetalis?
Type II HypersensitivityType II Hypersensitivity ( (Cytotoxic typeCytotoxic type))
APR-2015-CSBRP
APR-2015-CSBRP
Antibody mediated cellular Antibody mediated cellular dysfunctiondysfunction
Myasthenia Gravis Myasthenia Gravis – Ab react – Ab react with acetochyline receptor in the with acetochyline receptor in the motor end plate of skeletal motor end plate of skeletal muscle – muscle weaknessmuscle – muscle weakness
Graves diseaseGraves disease – Ab against TSH – Ab against TSH receptor on thyroid epithelial receptor on thyroid epithelial cells - Hyperthyroidismcells - Hyperthyroidism
APR-2015-CSBRP
APR-2015-CSBRP
Type II HypersensitivityType II Hypersensitivity (cytotoxic type) (cytotoxic type)
Good pasture syndrome – Good pasture syndrome – Type IV collagen of BM of glomeruli Type IV collagen of BM of glomeruli
and lung alveoliand lung alveoli Bullous pemphigoidBullous pemphigoid
Epithelial BM proteinEpithelial BM protein Pernicious anemiaPernicious anemia
Intrinsic factor and gastric parietal cellIntrinsic factor and gastric parietal cell Acute rheumatic feverAcute rheumatic fever
Ab against streptococus cross react Ab against streptococus cross react with heartwith heart
APR-2015-CSBRP
Goodpasture Syndrome
APR-2015-CSBRP
APR-2015-CSBRP
Bullous Bullous pemphigoidpemphigoid
APR-2015-CSBRP
Type III HypersensitivityType III Hypersensitivity((Immune Complex Immune Complex
MediatedMediated)) Antigen – Antibody complexes Antigen – Antibody complexes
produces tissue damage by produces tissue damage by eliciting inflammation at the site eliciting inflammation at the site of depositionof deposition
Circulating immune complexesCirculating immune complexes Deposited in vessel wallDeposited in vessel wall
In Situ immune complexesIn Situ immune complexes Extrasvascular placesExtrasvascular places
APR-2015-CSBRP
Type III HypersensitivityType III Hypersensitivity(Immune Complex (Immune Complex
Mediated)Mediated)Two types of AntigenTwo types of Antigen Exogenous AgExogenous Ag
Foreign protein, bacteria, virusForeign protein, bacteria, virus Endogenous AgEndogenous Ag
Circulating Ag in bloodCirculating Ag in blood Nuclear AgNuclear Ag
APR-2015-CSBRP
Systemic immune Systemic immune complex diseasecomplex disease
Acute serum sickness – injection Acute serum sickness – injection of horse serumof horse serum
3 phase3 phase Immune complex formationImmune complex formation Immune complex depositionImmune complex deposition Immune complex mediated Immune complex mediated
inflammationinflammation
APR-2015-CSBRP
Type III HypersensitivityType III Hypersensitivity(Immune Complex (Immune Complex
Mediated)Mediated) Factors affecting out come of immune Factors affecting out come of immune
complexcomplex Size of immune complexSize of immune complex Functional status of phagocyte systemFunctional status of phagocyte system
Charge of immune complex, affinity Charge of immune complex, affinity of Ag to various tissue component of Ag to various tissue component and hemodynamic factor influences and hemodynamic factor influences tissue deposition of immune complextissue deposition of immune complex
Glomeruli, joints, skin, heart, blood Glomeruli, joints, skin, heart, blood vesselvessel
APR-2015-CSBRP
Type III HypersensitivityType III Hypersensitivity(Immune Complex (Immune Complex
Mediated)Mediated) Immune complex deposited in tissue Immune complex deposited in tissue
elicit acute inflammatory reactionelicit acute inflammatory reaction Fever, Fever, urticariaurticaria, , arthralgiaarthralgia, lymph , lymph
node enlargement and node enlargement and proteinuriaproteinuria Activation of complement cascadeActivation of complement cascade – –
C3a, C5aC3a, C5a Activation of neutrophil & Activation of neutrophil &
macrophages through their Fc macrophages through their Fc receptorreceptor
APR-2015-CSBRP
APR-2015-CSBRP
APR-2015-CSBRP
Type III HypersensitivityType III Hypersensitivity(Immune Complex (Immune Complex
Mediated)Mediated) Release of proinflammatory Release of proinflammatory
mediatorsmediators PG, vasodilator peptides, chemotactic PG, vasodilator peptides, chemotactic
substances, lysosomal enzymes and substances, lysosomal enzymes and oxygen free radicals – tissue damageoxygen free radicals – tissue damage
Immune complex – platelet Immune complex – platelet aggregation & Hageman factor aggregation & Hageman factor activation – microthrombi formationactivation – microthrombi formation
Vasulitis / GlomerulonephritisVasulitis / Glomerulonephritis
APR-2015-CSBRP
Systemic immune Systemic immune complex diseasecomplex disease
MorphologyMorphology Acute necrotizing vasculitisAcute necrotizing vasculitis GlomerulonephritisGlomerulonephritis – –
SLE, Acute poststreptococcal GNSLE, Acute poststreptococcal GN Collagen disorderCollagen disorder
Rheumatoid arthritis, Rheumatoid arthritis, polyarteritis nodosa, polyarteritis nodosa,
APR-2015-CSBRP
Acute necrotizing Acute necrotizing vasculitisvasculitis
APR-2015-CSBRP
Local immune complex Local immune complex diseasedisease
((Arthus reactionArthus reaction)) Localized area of tissue necrosis Localized area of tissue necrosis
resulting from acute immune resulting from acute immune complex vasculitis usually in the complex vasculitis usually in the skinskin
Arthus lesion develop over few Arthus lesion develop over few hours & reaches peak 4-10 hours hours & reaches peak 4-10 hours after injectionafter injection
M/S – fibrinoid necrosis of vesselM/S – fibrinoid necrosis of vessel
APR-2015-CSBRP
Type IV HypersensitivityType IV Hypersensitivity(Cell mediated)(Cell mediated)
Intiated by specifically sensitized T Intiated by specifically sensitized T lymphocyteslymphocytes
Immunological reaction to M. Tuberculosis, Immunological reaction to M. Tuberculosis, virus, fungi, protozoa & parasitevirus, fungi, protozoa & parasite
Contact dermatitisContact dermatitis Graft rejectionGraft rejection
Two typesTwo types1.1. Classic delayed type hypersensitivity Classic delayed type hypersensitivity
reaction – mediated by CD4 T cellreaction – mediated by CD4 T cell2.2. Direct cell cytotoxicity - Mediated by CD8 Direct cell cytotoxicity - Mediated by CD8
T cellT cell
APR-2015-CSBRP
Classic delayed type Classic delayed type hypersensitivityhypersensitivity
Tuberculin reactionTuberculin reaction Protein lipopolysaccharide component Protein lipopolysaccharide component
of tubercle bacilliof tubercle bacilli Reddening & induration of site – 8-12 Reddening & induration of site – 8-12
hourshours Peak in 24 – 72 hoursPeak in 24 – 72 hours
M/SM/S Perivascular mononuclear cell Perivascular mononuclear cell
infiltrationinfiltration Edema & fibrin depositionEdema & fibrin deposition
APR-2015-CSBRP
Tuberculin testTuberculin test
APR-2015-CSBRP
Classic delayed type Classic delayed type hypersensitivityhypersensitivity
Persistent / nondegradable Ag – Persistent / nondegradable Ag – lymphocytes are replaced by lymphocytes are replaced by macrophages over 2 -3 weeks -- macrophages over 2 -3 weeks -- epithelioid cellsepithelioid cells
GranulomaGranuloma – microscopic – microscopic aggregate of epithelioid cells aggregate of epithelioid cells surrounded by collar of surrounded by collar of lymphocyteslymphocytes
APR-2015-CSBRP
Classic delayed type Classic delayed type hypersensitivityhypersensitivity
CytokinesCytokines IL-12IL-12 IFN γ IFN γ IL-2IL-2 TNFTNF
APR-2015-CSBRP
Figure 6-21Schematic illustration of the events that give rise to the formation of granulomas in cell-mediated (type IV) hypersensitivity reactions. Note the role played by T cell-derived cytokines.
APR-2015-CSBRP
Classic delayed type Classic delayed type hypersensitivityhypersensitivity
CytokinesCytokines IL-12IL-12
Derived from macrophageDerived from macrophage Differentiation of CD4+ helper cell Differentiation of CD4+ helper cell
to Tto THH1 cell1 cell Induces IFN γ secreation by T cell & Induces IFN γ secreation by T cell &
NK cellNK cell
APR-2015-CSBRP
Classic delayed type Classic delayed type hypersensitivityhypersensitivity
Interferon – gamma (IFN γ )Interferon – gamma (IFN γ ) Important mediator of delayed Important mediator of delayed
hypersensitivityhypersensitivity Powerful activator of macrophagesPowerful activator of macrophages Stimulate the secretion of IL – 12Stimulate the secretion of IL – 12 Express more class II molecule on the Express more class II molecule on the
surfacesurface ↑ ↑ capacity to kill micro organism/tumour capacity to kill micro organism/tumour
cellcell Secretes PDGF & TGF – β -- stimulate Secretes PDGF & TGF – β -- stimulate
fibroblast proliferation - fibrosisfibroblast proliferation - fibrosis
APR-2015-CSBRP
Classic delayed type Classic delayed type hypersensitivityhypersensitivity
IL – 2IL – 2 Autocrine & paracrine proliferation of T Autocrine & paracrine proliferation of T
cellscells TNF – α and lymphotoxinTNF – α and lymphotoxin
Act on endothelial cellsAct on endothelial cells ↑ ↑ secretion of prostacyclin – vasodilatationsecretion of prostacyclin – vasodilatation ↑ ↑ expression of E selectinexpression of E selectin Secretion of IL-8Secretion of IL-8Overall effect is extravasation & Overall effect is extravasation &
accumulation of lymphocyte and monocyte accumulation of lymphocyte and monocyte at the site of reactionat the site of reaction
APR-2015-CSBRP
Type VType V
Receptor type of Antibodies
APR-2015-CSBRP
Type V HypersensitivityType V HypersensitivityIgG antibodies against cell-surface receptors disrupt the normal functions of the receptor.
By causing :
- uncontrolled activation or
- by blocking receptor function.
APR-2015-CSBRP
APR-2015-CSBRP
E N DE N D
APR-2015-CSBRP